Uniphos Enterprises Share Price
Sector: Chemical Manufacturing
150.10 -3.15 (-2.06%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
148.00
Today’s High
156.70
52 Week Low
123.10
52 Week High
196.00
151.73 -2.46 (-1.60%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
147.59
Today’s High
155.30
52 Week Low
129.44
52 Week High
195.50
Key Metrics
- Market Cap (In Cr) 1048.33
- Beta 0.9
- Div. Yield (%) 0.33
- P/B 0.38
- TTM P/E 3835.75
- Sector P/E 0
- Open Price 152
- Prev Close 153.25
Uniphos Enterprises Analysis
Price Analysis
-
1 Week0.48%
-
3 Months-2.11%
-
6 Month-7.44%
-
YTD-4.48%
-
1 Year-10.11%
Risk Meter
- 42% Low risk
- 42% Moderate risk
- 42% Balanced Risk
- 42% High risk
- 42% Extreme risk
Uniphos Enterprises Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 111.51
- Selling/ General/ Admin Expenses Total
- 1.37
- Depreciation/ Amortization
- 0.75
- Other Operating Expenses Total
- 3.26
- Total Operating Expense
- 116.09
- Operating Income
- -4.57
- Net Income Before Taxes
- 0.23
- Net Income
- 0.28
- Diluted Normalized EPS
- 0.04
- Period
- 2025
- Total Assets
- 2841.71
- Total Liabilities
- 100.06
- Total Equity
- 2741.65
- Tangible Book Valueper Share Common Eq
- 394.22
- Period
- 2025
- Cashfrom Operating Activities
- -2.72
- Cashfrom Investing Activities
- 52.77
- Cashfrom Financing Activities
- -40.96
- Net Changein Cash
- 9.09
- Period
- 2024
- Total Revenue
- 50.65
- Selling/ General/ Admin Expenses Total
- 3.18
- Other Operating Expenses Total
- 0.01
- Total Operating Expense
- 54.57
- Operating Income
- -3.92
- Net Income Before Taxes
- 38.94
- Net Income
- 38.61
- Diluted Normalized EPS
- 5.55
- Period
- 2024
- Total Assets
- 2077.5
- Total Liabilities
- 2.05
- Total Equity
- 2075.45
- Tangible Book Valueper Share Common Eq
- 298.43
- Period
- 2024
- Cashfrom Operating Activities
- -3.47
- Cashfrom Investing Activities
- 50.16
- Cashfrom Financing Activities
- -45.2
- Net Changein Cash
- 1.49
- Period
- 2023
- Total Revenue
- 1.47
- Selling/ General/ Admin Expenses Total
- 2.87
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0
- Total Operating Expense
- 4.94
- Operating Income
- -3.47
- Net Income Before Taxes
- 39.62
- Net Income
- 39.23
- Diluted Normalized EPS
- 5.64
- Period
- 2023
- Total Assets
- 3095.47
- Total Liabilities
- 97.87
- Total Equity
- 2997.6
- Tangible Book Valueper Share Common Eq
- 431.02
- Period
- 2023
- Cashfrom Operating Activities
- -1.47
- Cashfrom Investing Activities
- 40.63
- Cashfrom Financing Activities
- -39.29
- Net Changein Cash
- -0.13
- Period
- 2022
- Total Revenue
- 1.22
- Selling/ General/ Admin Expenses Total
- 3.11
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.03
- Total Operating Expense
- 4.38
- Operating Income
- -3.16
- Net Income Before Taxes
- 53.94
- Net Income
- 54.6
- Diluted Normalized EPS
- 7.85
- Period
- 2022
- Total Assets
- 3301.57
- Total Liabilities
- 121.04
- Total Equity
- 3180.53
- Tangible Book Valueper Share Common Eq
- 457.33
- Period
- 2022
- Cashfrom Operating Activities
- 0.52
- Cashfrom Investing Activities
- 20.43
- Cashfrom Financing Activities
- -23.65
- Net Changein Cash
- -2.69
- Period
- 2021
- Total Revenue
- 0.83
- Selling/ General/ Admin Expenses Total
- 3.07
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.01
- Total Operating Expense
- 3.93
- Operating Income
- -3.1
- Net Income Before Taxes
- 23.4
- Net Income
- 24.45
- Diluted Normalized EPS
- 3.52
- Period
- 2021
- Total Assets
- 2771.61
- Total Liabilities
- 56.9
- Total Equity
- 2714.71
- Tangible Book Valueper Share Common Eq
- 390.35
- Period
- 2021
- Cashfrom Operating Activities
- -4.59
- Cashfrom Investing Activities
- -33.86
- Net Changein Cash
- -38.45
- Period
- 2020
- Total Revenue
- 0.23
- Selling/ General/ Admin Expenses Total
- 2.27
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0
- Total Operating Expense
- 2.53
- Operating Income
- -2.31
- Net Income Before Taxes
- 20.43
- Net Income
- 20.07
- Diluted Normalized EPS
- 2.89
- Period
- 2020
- Total Assets
- 1518.52
- Total Liabilities
- 0.71
- Total Equity
- 1517.81
- Tangible Book Valueper Share Common Eq
- 218.25
- Period
- 2020
- Cashfrom Operating Activities
- -2.11
- Cashfrom Investing Activities
- 44.19
- Net Changein Cash
- 42.09
- Period
- 2019
- Total Revenue
- 0
- Selling/ General/ Admin Expenses Total
- 2.79
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.02
- Total Operating Expense
- 2.85
- Operating Income
- -2.85
- Net Income Before Taxes
- 21.18
- Net Income
- 20.76
- Diluted Normalized EPS
- 2.99
- Period
- 2019
- Total Assets
- 2697.82
- Total Liabilities
- 0.18
- Total Equity
- 2697.64
- Tangible Book Valueper Share Common Eq
- 387.89
- Period
- 2019
- Cashfrom Operating Activities
- -3.21
- Cashfrom Investing Activities
- -1.94
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -5.16
- Period
- 2025-03-31
- Total Revenue
- 72.9
- Selling/ General/ Admin Expenses Total
- 0.43
- Depreciation/ Amortization
- 0.19
- Other Operating Expenses Total
- 1.58
- Total Operating Expense
- 74.68
- Operating Income
- -1.78
- Net Income Before Taxes
- -1.58
- Net Income
- -1.58
- Diluted Normalized EPS
- -0.23
- Period
- 2025-03-31
- Total Assets
- 2841.71
- Total Liabilities
- 100.06
- Total Equity
- 2741.65
- Tangible Book Valueper Share Common Eq
- 394.22
- Period
- 2025-03-31
- Cashfrom Operating Activities
- -2.72
- Cashfrom Investing Activities
- 52.77
- Cashfrom Financing Activities
- -40.96
- Net Changein Cash
- 9.09
- Period
- 2024-12-31
- Total Revenue
- 5.1
- Selling/ General/ Admin Expenses Total
- 0.57
- Depreciation/ Amortization
- 0.19
- Other Operating Expenses Total
- 0.48
- Total Operating Expense
- 6.29
- Operating Income
- -1.19
- Net Income Before Taxes
- -1.91
- Net Income
- -1.86
- Diluted Normalized EPS
- -0.27
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 30.48
- Selling/ General/ Admin Expenses Total
- 0.39
- Depreciation/ Amortization
- 0.19
- Other Operating Expenses Total
- 0.38
- Total Operating Expense
- 31.15
- Operating Income
- -0.67
- Net Income Before Taxes
- 3.86
- Net Income
- 3.86
- Diluted Normalized EPS
- 0.56
- Period
- 2024-09-30
- Total Assets
- 2694.36
- Total Liabilities
- 116.56
- Total Equity
- 2577.81
- Tangible Book Valueper Share Common Eq
- 370.66
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -1.62
- Cashfrom Investing Activities
- 10.53
- Cashfrom Financing Activities
- 0.22
- Net Changein Cash
- 9.12
- Period
- 2024-06-30
- Total Revenue
- 3.03
- Selling/ General/ Admin Expenses Total
- 0.41
- Depreciation/ Amortization
- 0.19
- Other Operating Expenses Total
- 0.38
- Total Operating Expense
- 3.97
- Operating Income
- -0.94
- Net Income Before Taxes
- -0.15
- Net Income
- -0.15
- Diluted Normalized EPS
- -0.02
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 50.65
- Selling/ General/ Admin Expenses Total
- 0.9
- Depreciation/ Amortization
- 0.21
- Other Operating Expenses Total
- 0.06
- Total Operating Expense
- 51.71
- Operating Income
- -1.07
- Net Income Before Taxes
- -0.42
- Net Income
- -0.63
- Diluted Normalized EPS
- -0.09
- Period
- 2024-03-31
- Total Assets
- 2077.5
- Total Liabilities
- 2.05
- Total Equity
- 2075.45
- Tangible Book Valueper Share Common Eq
- 298.43
- Period
- 2024-03-31
- Cashfrom Operating Activities
- -3.47
- Cashfrom Investing Activities
- 50.16
- Cashfrom Financing Activities
- -45.2
- Net Changein Cash
- 1.49
- Period
- 2023-12-31
- Total Revenue
- 0
- Selling/ General/ Admin Expenses Total
- 0.64
- Depreciation/ Amortization
- 0.21
- Other Operating Expenses Total
- 0.31
- Total Operating Expense
- 1.16
- Operating Income
- -1.16
- Net Income Before Taxes
- -0.03
- Net Income
- -0.03
- Diluted Normalized EPS
- 0
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Uniphos Enterprises Technical
Moving Average
SMA
- 5 Day151.94
- 10 Day151.7
- 20 Day155.42
- 50 Day156.89
- 100 Day153.58
- 300 Day158.43
Uniphos Enterprises Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Shree Pushkar Chemical & Ferti
- 331.9
- 21.8
- 7.03
- 384.5
- 195
- 1078.33
- Tgv Sraac
- 97.8
- -1.75
- -1.76
- 120.9
- 86.5
- 1047.34
- Uniphos Enterprises
- 150.1
- -3.15
- -2.06
- 196
- 123.1
- 1048.33
- Veritas India
- 385.75
- 7.55
- 2
- 1329.75
- 353.55
- 1034.19
- Tuticorin Alkali Chem And Fertil
- 80
- -0.01
- -0.01
- 112
- 72
- 974.81
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Shree Pushkar Chemical & Ferti
- 18.16
- 1.99
- 10.49
- 6.88
- Tgv Sraac
- 11.34
- 0.89
- 15.61
- 8.33
- Uniphos Enterprises
- 3755
- 0.38
- 1.2
- 94.86
- Veritas India
- 9.11
- 0.39
- 5.45
- 4.31
- Tuticorin Alkali Chem And Fertil
- 22.02
- 6.9
- -
- 10.21
Uniphos Enterprises Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 28-May-25
- Audited Results & Dividend
- 13-Feb-25
- Quarterly Results
- 14-Nov-24
- Quarterly Results
- 13-Aug-24
- Quarterly Results
- 28-May-24
- Audited Results & Dividend
- 13-Feb-24
- Quarterly Results
- 08-Nov-23
- Quarterly Results
- 09-Aug-23
- Quarterly Results
- 26-May-23
- Audited Results & Dividend
- 14-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 09-May-25
- 16-Apr-25
- EGM
- 20-Sept-24
- 27-Aug-24
- AGM
- 25-Aug-23
- 27-Jul-23
- AGM
- 07-Mar-22
- 09-Feb-22
- EGM
- 13-Aug-21
- 16-Jul-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 28-May-25
- -
- -
- 0.5
- 28-May-24
- -
- 06-Sept-24
- 5.7
- 26-May-23
- -
- 11-Aug-23
- 6.5
- 24-May-22
- -
- 04-Aug-22
- 5.65
- 26-May-21
- -
- 29-Jul-21
- 3.4


